Box score
Evogene Ltd.
Reported $3.4M sold in a new Form D filed February 19, 2026 (Rehovot, outside the US).
- Biggest raise
- $3.4M filed Feb 19, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Rehovot, outside the US
- Season rank
- #417 of 1,121 in the Bio & Health League; #3550 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 2
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-02-19 | New notice | $3.4M | $3.4M | SEC |
| 2024-09-04 | New notice not ranked | $0 | $12M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1574565.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Conavi Medical Corp. | Bio & Health | $3.5M |
| 2 | Polyrizon Ltd. rookie | Bio & Health | $3.5M |
| 3 | Edesa Biotech, Inc. | Bio & Health | $3.5M |
| 4 | NewcelX Ltd. | Bio & Health | $3.4M |
| 5 | Combat Medical Holdings Ltd rookie provisional | Bio & Health | $3.4M |
| 6 | BiomX Inc. | Bio & Health | $3.3M |